437 related articles for article (PubMed ID: 21927887)
1. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
[TBL] [Abstract][Full Text] [Related]
2. Acute Hemorrhagic Apoplectic Pituitary Adenoma: Endoscopic Management, Surgical Outcomes, and Complications.
Zhan R; Zhao Y; Wiebe TM; Li X
J Craniofac Surg; 2015 Sep; 26(6):e510-5. PubMed ID: 26335327
[TBL] [Abstract][Full Text] [Related]
3. Pituitary apoplexy in an adrenocorticotropin-producing pituitary macroadenoma.
Sahin SB; Cetinkalp S; Erdogan M; Cavdar U; Duygulu G; Saygili F; Yilmaz C; Ozgen AG
Endocrine; 2010 Oct; 38(2):143-6. PubMed ID: 21046475
[TBL] [Abstract][Full Text] [Related]
4. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
5. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
6. Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era.
Zaidi HA; Cote DJ; Burke WT; Castlen JP; Bi WL; Laws ER; Dunn IF
World Neurosurg; 2016 Dec; 96():434-439. PubMed ID: 27663263
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract][Full Text] [Related]
8. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
Ioachimescu AG
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of endoscopic transsphenoidal surgery for cushing's disease: Case series and review of the literature.
Masui K; Wajima D; Aketa S; Nishimura F
Neurol India; 2020; 68(2):403-406. PubMed ID: 32415015
[TBL] [Abstract][Full Text] [Related]
11. Pituitary Apoplexy due to the Diagnostic Test in a Cushing"s Disease Patient.
Kuzu F; Unal M; Gul S; Bayraktaroglu T
Turk Neurosurg; 2018; 28(2):323-325. PubMed ID: 27593808
[TBL] [Abstract][Full Text] [Related]
12. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.
Donofrio CA; Losa M; Gemma M; Giudice L; Barzaghi LR; Mortini P
Endocrine; 2017 Nov; 58(2):303-311. PubMed ID: 28005257
[TBL] [Abstract][Full Text] [Related]
13. Management and outcomes of pituitary apoplexy.
Singh TD; Valizadeh N; Meyer FB; Atkinson JL; Erickson D; Rabinstein AA
J Neurosurg; 2015 Jun; 122(6):1450-7. PubMed ID: 25859804
[TBL] [Abstract][Full Text] [Related]
14. Invasive ACTH-secreting pituitary macroadenoma in remission after transsphenoidal resection: A case report and literature review.
Zhuang Z; Liu X; Bao X; Pan B; Deng K; Yao Y; Lian W; Xing B; Zhu H; Lu L; Wang R; Feng M
Medicine (Baltimore); 2018 Nov; 97(46):e13148. PubMed ID: 30431585
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
Rollin G; Ferreira NP; Czepielewski MA
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous remission of hypercortisolism presumed due to asymptomatic tumor apoplexy in ACTH-producing pituitary macroadenoma.
Machado MC; Gadelha PS; Bronstein MD; Fragoso MC
Arq Bras Endocrinol Metabol; 2013 Aug; 57(6):486-9. PubMed ID: 24030190
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
[TBL] [Abstract][Full Text] [Related]
18. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months.
Elsässer Imboden PN; De Tribolet N; Lobrinus A; Gaillard RC; Portmann L; Pralong F; Gomez F
Medicine (Baltimore); 2005 May; 84(3):188-196. PubMed ID: 15879908
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Neurologic Outcome in Patients with Pituitary Apoplexy After Transsphenoidal Surgery.
Kim YH; Cho YH; Hong SH; Kim JH; Kim MS; Khang SK; Lee EJ; Chong K; Kim CJ
World Neurosurg; 2018 Mar; 111():e18-e23. PubMed ID: 29191540
[TBL] [Abstract][Full Text] [Related]
20. Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.
Araki T; Sangtian J; Ruanpeng D; Tummala R; Clark B; Burmeister L; Peterson D; Venteicher AS; Kawakami Y
Pituitary; 2021 Dec; 24(6):859-866. PubMed ID: 34041660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
